Pharmacological networks have indicated that PI3K/AKT, TNF, MAPK, and p53 are the main components through which SKI affects cisplatin (CDDP)-induced AKI, potentially modulating pathways associated with inflammation, oxidative stress, and apoptosis [29]. Here, TP53 is linked to acute kidney injury.